Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
Vasiliadou I, Grose D, Wilson C, Thapa A, Donnelly O, Lee E, Leslie I, Karim M, Hartley A, Partridge S, Medlow K, De Boisanger J, Metcalf R, Williamson A, Haridass A, Noble D, Mactier K, Walter H, Ma N, De Winton E, Cohen J, Rayner L, Geropantas K, Jankowska P, Mason J, Moleron R, Laws K, Ulahannan D, Nallathambi C, Michaelidou A, Nallamilli S, Raouf S, Palmer K, Bienz M, Karet T, Khalique S, Paterson C, Harrington K, Bhide S, Kong A. Vasiliadou I, et al. Among authors: grose d. Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34963. Online ahead of print. Int J Cancer. 2024. PMID: 38685816
The UK Divide: Does Having a Pembrolizumab-Chemotherapy Option in Head and Neck Cancer Matter? Real-world Experience of First-line Palliative Pembrolizumab Monotherapy and Pembrolizumab-Chemotherapy Combination in Scotland.
Thapa A, Cowell A, Peters A, Noble DJ, James A, Lamb C, Grose D, Vohra S, Schipani S, Mactier K, Mackenzie J, Srinivasan D, Laws K, Moleron R, Niblock P, Soh FY, Paterson C, Wilson C. Thapa A, et al. Among authors: grose d. Clin Oncol (R Coll Radiol). 2024 May;36(5):287-299. doi: 10.1016/j.clon.2024.02.004. Epub 2024 Feb 12. Clin Oncol (R Coll Radiol). 2024. PMID: 38395634
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.
Olson R, Abraham H, Leclerc C, Benny A, Baker S, Matthews Q, Chng N, Bergman A, Mou B, Dunne EM, Schellenberg D, Jiang W, Chan E, Atrchian S, Lefresne S, Carolan H, Valev B, Tyldesley S, Bang A, Berrang T, Clark H, Hsu F, Louie AV, Warner A, Palma DA, Howell D, Barry A, Dawson L, Grendarova P, Walker D, Sinha R, Tsai J, Bahig H, Thibault I, Koul R, Senthi S, Phillips I, Grose D, Kelly P, Armstrong J, McDermott R, Johnstone C, Vasan S, Aherne N, Harrow S, Liu M. Olson R, et al. Among authors: grose d. BMC Cancer. 2024 Feb 3;24(1):171. doi: 10.1186/s12885-024-11905-7. BMC Cancer. 2024. PMID: 38310262 Free PMC article.
The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Advanced Head and Neck Squamous Cell Carcinoma.
Zhou S, Chan C, Lau YC, Rulach R, Dyab H, Hendry F, Wilson C, Schipani S, Lamb C, Grose D, James A, Maxfield C, Dempsey MF, Paterson C. Zhou S, et al. Among authors: grose d. Clin Oncol (R Coll Radiol). 2023 Dec;35(12):e699-e707. doi: 10.1016/j.clon.2023.09.006. Epub 2023 Sep 22. Clin Oncol (R Coll Radiol). 2023. PMID: 37798198
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
Zhou S, Chan C, Rulach R, Dyab H, Hendry F, Maxfield C, Dempsey MF, James A, Grose D, Lamb C, Schipani S, Wilson C, Cheng Lau Y, Paterson C. Zhou S, et al. Among authors: grose d. Oral Oncol. 2022 May;128:105870. doi: 10.1016/j.oraloncology.2022.105870. Epub 2022 Apr 18. Oral Oncol. 2022. PMID: 35447564
54 results